Recombinant Antibody Guide For Beginners | Boster Bio

• Direct contact technical support
• Find products for your research

Recombinant antibodies are antibodies produced through genetic engineering technology, playing a significant role in modern biomedical research and applications. Traditional antibodies are usually generated by immunizing animals, whereas recombinant antibodies are obtained by synthesizing antibody genes in vitro and then expressing and purifying them.

Here are the brief steps of recombinant antibody production:

• Hybridoma Sequencing: Sequence the antibody genes from hybridoma cells to obtain the recombinant antibody gene sequence.
• Gene Synthesis: Synthesize the heavy and light chain genes of the antibody, based on the sequencing results, preparing them for subsequent expression.
• Plasmid Preparation: Clone the synthesized antibody genes into an expression vector (plasmid), ready for transfection.
• Cell Transfection & Culture: Transfect the plasmid into host cells (such as CHO or HEK293 cells) and culture the cells in a medium to express the antibody.
• Protein Purification: Isolate and purify the antibody from the cell culture medium to ensure high-purity target protein.
• Recombinant Antibody Delivery: Package the purified recombinant antibody and prepare it for delivery to the customer or laboratory for further research.

Advantages and Disadvantages of Recombinant Antibodies

Recombinant antibodies have many significant advantages in the field of biological research, diagnosis, and therapy. First, they are produced through genetic engineering technology, which means that the antibody sequence can be precisely controlled, thus achieving a high degree of consistency and repeatability. Compared with conventional antibodies, the recombinant antibodies do not differ from batch to batch, ensuring the reliability of the study results and the controllability of the experiment. In addition, the production process of recombinant antibodies does not rely on the animal immune system, avoiding the ethical issues of traditional antibody production, while reducing the risk of animal-derived contamination. This control makes recombinant antibodies particularly suitable for demanding applications, such as precise diagnostics and molecular labeling. Recombinant antibodies can also be further optimized through genetic engineering techniques, such as increasing affinity, specificity, or stability for use under harsh conditions, extending their applicability in complex experimental environments.

However, recombinant antibodies also have some limitations. First, its production cost is high, especially when generating and optimizing antibodies with high affinity and high specificity, the cost may be much higher than that of traditional antibodies. In addition, the production process is complex, involving multiple steps such as gene cloning, expression system optimization, and purification, which can lead to a long production time and the need for highly specialized technical support.

Application Area:

Recombinant antibodies have a wide range of applications across research, diagnostics, and therapeutics. In research, they are used to detect and quantify the expression of specific proteins in techniques such as Western blotting, immunoprecipitation, and immunofluorescence. Recombinant antibodies are also widely employed in flow cytometry to detect markers on or within cells.

In diagnostics, recombinant antibodies are favored for their high specificity and consistency, making them ideal for ELISA and immunohistochemistry kits, which help identify biomarkers. They play a crucial role in the early diagnosis of infectious diseases, cancer markers, and cardiovascular conditions.

In therapeutics, recombinant antibodies are used extensively for treating cancer, autoimmune diseases, and infectious diseases. Antibody drugs, such as PD-1 and PD-L1 antibodies, have shown significant effects in cancer immunotherapy. Additionally, recombinant antibodies are used to neutralize viruses and modulate immune responses, making them a vital component of emerging antibody therapies. These diverse applications highlight the immense potential of recombinant antibodies.

Boster Recombinant Antibodies

Boster offers high-affinity recombinant antibodies. Our antibodies are produced with advanced genetic engineering techniques and ensure exceptional specificity and consistency. They are meticulously validated for various applications, including Western blotting, immunohistochemistry (IHC), and immunocytochemistry (ICC). With minimal batch-to-batch variability, Boster’s recombinant antibodies provide reliable and reproducible results. Explore our extensive catalog to find the ideal antibody for your research needs and elevate your experiments to the next level.